(Q72905642)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6268277%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6268277%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects (English)

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

11 September 2023

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

11 September 2023

1 reference

R. T. Chlebowski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6268277

11 September 2023

K. K. Chan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6268277

11 September 2023

M. J. Tong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6268277

11 September 2023

J. M. Weiner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6268277

11 September 2023

V. M. Ryden

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6268277

11 September 2023

J. R. Bateman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6268277

11 September 2023

language of work or name

English

0 references

publication date

1 September 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6268277%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

30 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

11 September 2023

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

11 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6268277%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6268277%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6268277%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

1088-1095

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6268277%20AND%20SRC:MED&resulttype=core&format=json

A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients

30 October 2019

cites work

2

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication

11 September 2023

3

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

11 September 2023

Cancer Treatment Reports

4

61

1385

Ihde

1977

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States

11 September 2023

5

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

11 September 2023

6

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

5-Fluorouracil in hepatocellular carcinoma.Report of twenty-one cases

11 September 2023

8

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Oral fluorouracil therapy of hepatoma

11 September 2023

9

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy.

11 September 2023

10

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations

11 September 2023

11

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma

11 September 2023

12

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan

11 September 2023

13

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

The metabolism of methaqualone in patients with biliary cirrhosis or secondary carcinoma of the liver

11 September 2023

15

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

11 September 2023

17

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Cancer chemotherapy reports

11 September 2023

18

60

1611

Watson

1976

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Proceedings of the American Association for Cancer Research

11 September 2023

21

21

176

Evans

1980

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

11 September 2023

Cancer Treatment Reports

22

35

1357

Chan

1978

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay

11 September 2023

23

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Cancer chemotherapy reports

11 September 2023

24

3

153

Bachur

1975

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology report

11 September 2023

25

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Hexobarbital disposition in compensated and decompensated cirrhosis of the liver

11 September 2023

26

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

11 September 2023

27

28

412a

Chlebowski

1980

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

11 September 2023

Cancer Treatment Reports

28

61

1595

Baker

1977

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Proceedings of the American Association for Cancer Research

11 September 2023

29

20

415

Ravry

1979

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Carcinoembryonic antigen concentrations in undiagnosed patients

11 September 2023

30

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

Carcinoembryonic antigen in liver disease

11 September 2023

31

1 reference

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19810901)48:5%3C1088::AID-CNCR2820480507%3E3.0.CO;2-W

11 September 2023

Identifiers

10.1002/1097-0142(19810901)48:5<1088::AID-CNCR2820480507>3.0.CO;2-W

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6268277%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference